文献速递免疫规划传染病防控与疫情报告

疫苗接种抑制小鼠角结膜炎模型中的人腺病毒转导

Vaccination inhibits the human adenoviral transduction in a mouse keratoconjunctivitis model.
PubMed 文献 · Vaccine · 2021-05-17

本研究在小鼠腺病毒角结膜炎模型中,评估肌内或鼻内接种E1/E3缺失的5型腺病毒(Ad5)载体疫苗对后续滴眼攻击的Ad5-Luci转导的抑制作用。疫苗诱导了多能CD8 T细胞反应和中和抗体,初次免疫8周后攻击显示转导显著降低>70%,肌内接种略优于鼻内;肌内接种10个月后仍维持高达60%的转导减少。被动免疫和CD8 T细胞清除实验提示细胞与体液免疫均参与保护。

要点

  • Ad5载体疫苗肌内或鼻内接种可诱导多能CD8 T细胞和中和抗体反应。
  • 初次免疫8周后,疫苗组小鼠角膜结膜组织Ad5-Luci转导显著降低>70%。
  • 肌内接种10个月后仍维持高达60%的转导减少,提示持久保护。

核心结论

  • Ad载体疫苗接种成功诱导适应性免疫反应,阻止小鼠角结膜炎模型中角膜和结膜相关组织的后续Ad转导。
  • 细胞免疫和体液免疫在预防Ad转导中均发挥重要作用。

研究设计与样本

  • 使用E1/E3缺失的Ad5载体疫苗,通过肌内或鼻内途径免疫小鼠,随后用表达荧光素酶的Ad5(Ad5-Luci)载体滴眼攻击。
  • 评估脾细胞中CD8 T细胞反应、血清中和Ad5抗体及眼洗液Ad5抗体,并在初次免疫后8周和10个月检测转导抑制。

主要发现

  • 疫苗诱导了强大的多能CD8 T细胞反应和中和Ad5抗体。
  • 初次免疫8周后攻击,疫苗组小鼠转导显著降低>70%,肌内接种略优于鼻内接种。
  • 肌内初次免疫10个月后仍观察到对后续攻击的抵抗力,Ad5-Luci转导持续减少高达60%。
  • 被动免疫 naive 小鼠 with 肌内接种小鼠抗血清后,Ad5-Luci转导效率约损失40%。
  • 肌内免疫小鼠在Ad8局部攻击后,有或无CD8 T细胞清除时Ad8基因组拷贝分别减少>40%和70%。

临床怎么用

  • 提示Ad载体疫苗可能用于预防腺病毒角结膜炎,肌内接种可能提供更优且持久的保护。
  • 细胞和体液免疫均参与保护,疫苗设计需兼顾两者。

局限性

  • 研究为小鼠模型,结果外推至人类需进一步验证。
  • 未报告疫苗在人体中的安全性、免疫原性或保护效力数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Adenovirus infections are a major cause of epidemic keratoconjunctivitis (EKC), which can lead to corneal subepithelial infiltrates and multifocal corneal opacity. In the current study, we investigated the use of an E1/E3-deleted adenovirus serotype 5 (Ad5) vector as a vaccine administered intramuscularly (IM) or intranasally (IN) against subsequent challenges with a luciferase-expressing Ad5 (Ad5-Luci) vector via eyedrop. We evaluated the adaptive immune response to Ad5 vector vaccination and confirmed a robust polyfunctional CD8 T cell response in splenic cells. Neutralizing Ad5 antibodies were also measured in the sera of vaccinated mice as well as Ad5 antibody in the eye wash solutions. Upon challenge with Ad5-Luci vector 8 weeks post the primary immunization, transduction was significantly reduced by > 70% in the vaccinated mice, which was slightly better in IM- vs. that in IN-vaccinated animals. Resistance to subsequent challenge was observed 10 months post primary IM vaccination, with sustained reduction up to 60% in the Ad5-Luci vector transduction. Passive immunization of naive mice with antisera from IM to vaccinated mice subsequently challenged with the Ad5-Luci vector resulted in approximately 40% loss in transduction efficiency. Furthermore, the mice that received IM immunization with or without CD8 T cell depletion showed > 40% and 70% reductions, respectively, in Ad8 genomic copies after Ad8 topical challenge. We conclude that Ad-vector vaccination successfully induced an adaptive immune response that prevented subsequent Ad transduction in the cornea and conjunctiva-associated tissues in a mouse model of adenovirus keratoconjunctivitis, and that both cellular and humoral immunity play an important role in preventing Ad transduction.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Fukuda M, Nakamura J, Ito S, et al. Vaccination inhibits the human adenoviral transduction in a mouse keratoconjunctivitis model. Vaccine. 2021. PMID: 34016474. doi:10.1016/j.vaccine.2021.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。